why choose us

First received: January 24, 2023

Clinical Trial: vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

Study Status: Completed

Recruit Status: RECRUITING

Condition: Liver Cancer

Study Type: INTERVENTIONAL


Official Title: vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

Brief Summary: This trial will provide the maximum tolerated dose for radiation therapy for liver tumors and describe the toxicity profile using the vGRID therapy technique.Based on trials using this type of radiation in other cancers demonstrating low toxicity rates even with very high radiation doses and high efficacy, it is likely that vGRID therapy in this trial will be well tolerated and allow dose escalation beyond currently common doses for liver tumors.

Read more